Clinical Evaluation of the Scopio Cell Morphology Technology
NCT06574308 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2024-08-27
Summary
Digital morphology is currently expanding and developing new applications based on artificial intelligence software. We recently published a study comparing screen validation and microscopic reading of bone marrow aspirates. The aim of the current research will be the comparison between optical microscope reading and automatic pre-classification (AI based)
Conditions
Interventions
- DIAGNOSTIC_TEST
-
Blood cells classification
Comparison of the classification of peripheral blood and bone marrow cells with optical microscope reading with pre-classification using Scopio technology (AI based)
Sponsors & Collaborators
-
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
lead OTHER
Principal Investigators
-
Patrizia Chiusolo · Fondazione Policlinico Universitario A. Gemelli, IRCCS
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-09-01
- Primary Completion
- 2025-09-01
- Completion
- 2025-09-01
Countries
- Italy
Study Locations
More Related Trials
-
GENomic PROfilation for Therapeutic Purposes in SARComas and Molecular Tumor Board (MTB): Retrospective/Prospective Study in Referral Centers
NCT06076070 ·Status: UNKNOWN
-
Single-cell RNAseq Breast Cancer
NCT05807516 ·Status: UNKNOWN
-
A Study on the Prevalence of Clinically Useful Mutations in Solid Tumor Characterized by Next Generation Sequencing Methods on Liquid Biopsy Analysis (POPCORN)
NCT06028724 ·Status: RECRUITING
-
Assessment of Circulating Tumor Cells and microRNAs in Patients With Metastatic Non-cutaneous Melanoma
NCT06863870 ·Status: ACTIVE_NOT_RECRUITING
-
Spatial Profile of Tumors
NCT06298773 ·Status: NOT_YET_RECRUITING
-
The Prognostic Value of Serum Biomarkers in Osteosarcoma
NCT05093101 ·Status: COMPLETED
-
Tumor Antigen Discovery for Innovative Cancer Immunotherapies in HCC: from Benchside to Bedside (HepAnt)
NCT06905262 ·Status: RECRUITING
-
Prospective and Retrospective Cohort Study to Find New Prognostic Factors and Therapeutic Targets in Patients With Newly Diagnosed or Relapsed Malignant Hematologic Disorder Excluding Acute Leukemia
NCT02330718 ·Status: UNKNOWN
-
Stratification of Cutaneous Squamous Cell Carcinomas According to Its Transcriptomic, Metabolic and Inflammatory Characteristics
NCT06476964 ·Status: RECRUITING ·Phase: NA
-
Detection of Circulating Tumor Cells in Patients With Sarcomas
NCT02983539 ·Status: UNKNOWN
-
Peripheral Blood and/or Bone Marrow, Including Detection of Occult Metastases, in Patients With Melanoma
NCT00588198 ·Status: COMPLETED
-
Integrated Multiomics and Multilevel Characterization of Haematological Disorders and Malignancies
NCT04298892 ·Status: UNKNOWN
-
Study Of Circulating Multiple Myeloma Cells As A Biomarker of MGUS And SMM
NCT01958528 ·Status: COMPLETED
-
Biology and Genetics of Smouldering Myeloma
NCT05047107 ·Status: UNKNOWN
-
Bone Marrow and Blood Samples From Patients With Metastatic Choroid Melanoma
NCT00897624 ·Status: COMPLETED
-
A Study of Observation and Follow-up in People With Basal Cell Carcinoma
NCT05473507 ·Status: ACTIVE_NOT_RECRUITING
-
Validation of Molecular Diagnostic Assays to Detect Cancer Biomarkers in Blood and Primary Tumor in HNSCC/NSCLC/Melanoma
NCT04490564 ·Status: COMPLETED
-
Hypercoagulation Screening in Cancer
NCT02622815 ·Status: UNKNOWN
-
Investigate eNAMPT in Multiple Myeloma Biology and Establish Its Role in Disease Progression
NCT04137523 ·Status: COMPLETED
-
Diagnosing Melanoma, Squamous Cell Carcinoma and Basal Cell Carcinoma Using the Spectra-Scope
NCT03069846 ·Status: UNKNOWN ·Phase: NA
-
Clinical Application of Liquid Biopsy for Precise Diagnosis and Prognosis in Lymphoma
NCT04062877 ·Status: COMPLETED
-
Detection of Circulating Osteosarcoma Tumor Cells in the Blood of Patients Using the Polymerase Chain Reaction
NCT00588510 ·Status: COMPLETED
-
Role of Microbiome as a Biomarkers in Locoregionally-Advanced Oropharyngeal Squamous Cell Carcinoma
NCT03759730 ·Status: COMPLETED
-
Metastatic Leiomyosarcoma Biomarker Protocol
NCT05653388 ·Status: RECRUITING
-
Serum Histone Succinylation as a Novel Prognostic Biomarker in Hematological Malignancies
NCT07131449 ·Status: NOT_YET_RECRUITING